Open AccessSARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
Author(s) -
Alexandra Van Uytvanck,
Sebastian Wittnebel,
Nathalie Meuleman,
Angela Loizidou,
JeanCorentin Salengros,
Chloé Spilleboudt
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4439
Subject(s) - medicine , immunosuppression , myeloid leukemia , transplantation , hematopoietic stem cell transplantation , covid-19 , stem cell , leukemia , immunology , intensive care medicine , disease , infectious disease (medical specialty) , biology , genetics
Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.